Intarcia Therapeutics

The first and only once-yearly, injection-free, GLP-1 therapy for the treatment of type 2 diabetes.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Intarcia Therapeutics plus 5766 other startups.

Get A Demo

Learn More About Intarcia Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With